What Is Ovarian Cancer?

This content has been reviewed and approved by

Maurie Markman, MD
Vice President, Clinical Research
MD Anderson Cancer Center
University of Texas
 

If you've received a diagnosis of cancer in one or both of your ovaries, you should know that you are not alone. Ovarian cancer will be the eighth most commonly diagnosed form of cancer in women in the United States in 2008. It will account for an estimated 3 percent of all new cancer cases in women, according to estimates from the American Cancer Society (ACS). One out of every 58 women in the United States will have ovarian cancer sometime during their lives.

The ovaries are small (about the size of an almond) female reproductive organs that reside in the pelvis. There are two ovaries, one on each side of the uterus, or womb.

The ovaries produce the female hormones: estrogen and progesterone. Estrogen and progesterone control the development of female body characteristics (i.e., breasts, body shape, and body hair) and regulate the menstrual cycle and pregnancy. The ovaries also store all of the egg cells, a vital part of human reproduction.


 

Click Image to Enlarge

Some ovarian tumors are benign (not cancerous). Malignant (cancerous) ovarian tumors can originate from cells found in an ovary. There are three types of ovarian tumors named for the tissue in which they are found:

  • Epithelial cell - cells that cover the surface of the ovary
  • Germ cell - cells that form the eggs in the ovary
  • Stromal cell - cells that form the ovary and produce female hormones

The majority of ovarian cancers develop from cells in the lining of the ovary. Most of these tumors are benign (noncancerous). However, epithelial ovarian cancer accounts for 85 percent to 90 percent of ovarian cancer cases.

This content was last modified on July 23, 2007 .
Latest Ovarian Cancer News
Hormone therapy may up risk of dying of lung cancer

September 21, 2009 — NEW YORK (Reuters Health) - Among women who already have lung cancer, hormone replacement therapy - which has been tied to a higher risk of serious conditions including breast cancer and heart attacks - seems to increase the risk of death from the tumor, according to a new study.

New pill shows promise in hard-to-treat cancers

September 3, 2009 — CHICAGO (Reuters) - An experimental cancer pill shrank tumors in patients whose skin cancer had spread, raising hope for a new class of drugs that may have an affect on many other cancers as well, U.S. researchers said on Wednesday.

Nanotech gene therapy kills ovarian cancer in mice

July 30, 2009 — CHICAGO (Reuters) - Tiny synthetic particles carrying a payload of toxin worked as well as chemotherapy at killing ovarian cancer cells in mice, without the bad side effects, U.S. researchers said on Thursday.

Select news items provided by Reuters Health